This controversial provision of the Affordable Care Act has its proponents and its critics, but, as it goes into effect, this panel will focus on its likely impact on the public health and all the stakeholders — government, lawyers and accountants, the pharmaceutical and medical device industries, researchers and investigators, physicians, and others. The panelists, representing a cross-section of interest areas, will take a look at the burdens and benefits, the potential impact on clinical research, the advantages offered by the resultant transparency and how all of this will play out with the public and organized medicine.

Learning Objectives:
Discuss the Physician Payment Act and its likely impact on the public health and all stakeholders.